Nuclide Therapeutics raised €5.7M in a funding round in Sep 2025. The company is based in London, UK. Investors in the round: Marathon Beteiligungs AG. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €5.7M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
